A global private equity firm has confirmed it does not intend make an offer for Advanced Medical Solutions Group (AMS), a Cheshire-headquartered developer and manufacturer of innovative tissue-healing technology.
In April, AMS revealed it was in discussions with Boston-headquartered TA Associates regarding a possible offer.
It represented the latest expression of interest in the listed business from private equity, after talks with Montagu Private Equity last year. Bridgepoint has also been linked to AMS.
Now, TA Associates has said it does not plan to make an offer unless certain criteria emerge such as a rival proposal being made.
In a statement, AMS said: "The board of AMS remains confident in AMS' standalone prospects and strategy which it believes will continue to deliver sustainable growth and value creation for shareholders."
For the full story, see Insider Media